Cigna Corp. (CI) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CI Hot Sheet
Price: $305.41 --0%
Revenue Growth %: +4.2%
Financial Fact:
Net Income: 452M
Today's EPS Names:
KTB, CABO, FDUS, More
Revenue Growth %: +4.2%
Financial Fact:
Net Income: 452M
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
Cigna Corp. (NYSE: CI) reported Q2 EPS of $7.78, $0.19 better than the analyst estimate of $7.59. Revenue for the quarter came in at $71.7 billion versus the consensus estimate of $70.18 billion.
GUIDANCE:
Cigna Corp. sees FY2026 EPS of $30.45, versus the consensus of $30.41.
For earnings history and earnings-related data on Cigna Corp. (CI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ecovyst Inc. (ECVT) Tops Q3 EPS by 2c
- Myriad Genetics (MYGN) Tops Q3 EPS by 9c ; Offers Guidance
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
